In the March 2008 issue of this journal, investigators from the Pediatric Intensive Care Unit (PICU) at Gregorio Maranon General University Hospital in Spain addressed the issue of safety of transpyloric enteral nutrition in critically ill children in a single center, prospective, cross sectional, observational trial (Lopez-Herce et al., 2008) . The trial was performed over 10 years and included 526 patients admitted to a PICU. The objective of the study was to analyze the risk factors for gastrointestinal complications and adverse effects of transpyloric nutrition in critically ill children.
The group reported the incidence of gastrointestinal complications in patients fed with transpyloric enteral nutrition as 11.5%, though only 2.1% of patients required enteral nutrition to be suspended because of gastrointestinal complications. In one patient, death was related to the complications of transpyloric feeding. The most frequently identified risk factors for gastrointestinal complications were shock, acute renal failure, hypokalemia, hypophosphatemia, and use of dopamine, epinephrine or vecuronium. Stepwise multivariate logistic regression analysis identified shock, epinephrine infusion at a rate higher than 0.3 mg/kg/min and hypophosphatemia as the most important factors associated with gastrointestinal complications. The authors conclude that transpyloric nutrition can be considered safe in most PICU patients.
However, some questions remain with regard to the study validity. The patient population was well defined in terms of the time period during which patients were enrolled in the study and also the criteria for receiving transpyloric nutrition. However, the study population is described as 'all critically ill children' admitted to the PICU and the reader is left confused as to whether the population studied included all children admitted, or a subset of children defined as critically ill using some criteria which were not specified in the article.
The authors do not give a severity of illness score, or information on the previous nutritional status or comorbidities of the population. Moreover, no subgroup analysis according to age or weight is done, and there is no defined time frame in which children were followed up-Was followup until termination of the transpyloric nutrition or discharge from the PICU? The definition of failure of transpyloric enteral nutrition was also incomplete with no precise definition of what is meant by the terms 'significant' abdominal distension and 'severe' diarrhea.
Though some risk factors reached high statistical significance, the results were characterized by wide confidence intervals. Additionally, for certain 'risk factors' it is difficult to establish a cause-effect relationship; for example, it is impossible to distinguish whether the hypophosphatemia and hypokalemia were risk factors for complications or consequences of transpyloric feeding.
The authors conclude that 'the incidence of digestive tract complications in critically ill children fed with transpyloric enteral nutrition is low'. Though most of the complications were mild, we feel that an incidence of 11% of children developing complications should not be considered low. We believe that transpyloric nutrition should be used with caution in critically ill children with shock or who are on high inotropic support, and that electrolyte abnormalities should be corrected before commencing transpyloric enteral nutrition.
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